Paper 61 - CROSS-SPECIES COMPARATIVE ONCOLOGY APPROACHES FOR MODELING FUSION-DRIVEN INFANTILE RHABDOMYOSARCOMA

Co-Author(s)

• DC

  Delia Calderon, MS

  Nationwide Children's Hospital / The Ohio State University
  Columbus, Ohio, United States
• CS

  Chinmay Sankhe, Ph.D.

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• CT

  Cenny Taslim, Ph.D.

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• 

  Sarah Watson, MD, PhD

  Dr
  Curie
  Paris, Ile-de-France, France
• CL

  Collette LaVigne, MS

  UT Southwestern Medical Center
  Dallas, Texas, United States
• LX

  Lin Xu, Ph.D.

  UT Southwestern Medical Center
  Dallas, Texas, United States
• DS

  Didier Surdez, PhD, PharmD

  Balgrist University Hospital
  Zurich, Zurich, Switzerland
• JC

  Joanna Cyrta, MD, PhD

  Institut Curie
  Paris, Ile-de-France, France
• MC

  Matthew V. Cannon, PhD

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• MK

  Matthew Kent, Ph.D.

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• KS

  Katherine Silvius, BS

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• JK

  Jack Kucinski, MS

  Nationwide Children's Hospital / The Ohio State University
  Columbus, Ohio, United States
• EH

  Emma Harrison, BS

  Nationwide Children's Hospital
  Columbus, Ohio, United States
• DR

  Dinesh Rakheja, MD

  UT Southwestern Medical Center
  Dallas, Texas, United States
• FT

  Franck Tirode, Ph.D.

  Université Claude Bernard Lyon 1
  Lyon, Rhone-Alpes, France
• OD

  Olivier Delattre, MD, PhD

  Institut Curie
  Paris, Ile-de-France, France
• 

  James F. Amatruda, MD, PhD

  Director, Cancer and Blood Disease Institute
  Children's Hospital Los Angeles
  Los Angeles, California, United States

Author(s)

• 

  Genevieve C. Kendall, PhD

  Assistant Professor
  Nationwide Children's Hospital / The Ohio State University
  Columbus, Ohio, United States

  Slides